lisuride has been researched along with quinagolide in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Caruso, E; Colao, A; Di Sarno, A; Di Somma, C; Lombardi, G; Merola, B; Sarnacchiaro, F | 1 |
| Geyer, G; Knosp, E; Luger, A; Svoboda, T | 1 |
| Auriemma, RS; Colao, A; Negri, M; Patalano, R; Pirchio, R; Pivonello, C; Pivonello, R | 1 |
1 review(s) available for lisuride and quinagolide
| Article | Year |
|---|---|
Resistance to Dopamine Agonists in Pituitary Tumors: Molecular Mechanisms.
Topics: ACTH-Secreting Pituitary Adenoma; Adenoma; Aminoquinolines; beta-Arrestins; Bromocriptine; Cabergoline; Dopamine Agonists; Drug Resistance, Neoplasm; Filamins; Growth Hormone-Secreting Pituitary Adenoma; Humans; Lisuride; MicroRNAs; Pergolide; Pituitary Neoplasms; Prolactinoma; Receptors, Dopamine D2 | 2021 |
1 trial(s) available for lisuride and quinagolide
| Article | Year |
|---|---|
[Treatment of prolactinoma with a new dopamine agonist].
Topics: Adult; Aged; Aminoquinolines; Bromocriptine; Dopamine Agents; Female; Humans; Lisuride; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Prolactinoma; Time Factors | 1991 |
1 other study(ies) available for lisuride and quinagolide
| Article | Year |
|---|---|
Usefulness of CV 205-502 in a case of allergy to ergot-derived drugs.
Topics: Adult; Aminoquinolines; Bromocriptine; Drug Hypersensitivity; Female; Humans; Lisuride; Pituitary Neoplasms; Prolactin; Prolactinoma | 1992 |